Ruthenium(II) Complexes as Potential Apoptosis Inducers in Cancer Therapy (original) (raw)
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials
Enju Wang
Chemical Society reviews, 2017
View PDFchevron_right
Ruthenium(II) Complexes Containing Anti-Inflammatory Drugs as Ligands: Synthesis, Characterization andin vitroCytotoxicity Activities on Cancer Cell Lines
Gustavo Von Poelhsitz
Journal of the Brazilian Chemical Society, 2015
View PDFchevron_right
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
Joanna Wietrzyk
Materials, 2020
View PDFchevron_right
Toxicity of Ruthenium Complexes in Tumour Cell Lines
Philip Böhler
View PDFchevron_right
Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl2L] and Their Cytotoxicity against HeLa-Type Cancer Cells
José Manuel Huitzacua Pérez
Molecules
View PDFchevron_right
Novel mononuclear Ruthenium(II) compounds in cancer therapy. APJCP/1513-7368/2012; 13(7): p3293-3298.
yerra rajeshwar
View PDFchevron_right
Synthesis, spectroscopic characterization, antineoplastic, in vitro-cytotoxic, and antibacterial activities of mononuclear ruthenium(II) complexes. JCC/1029-0389/2012; 65(5): p823-839.
yerra rajeshwar
View PDFchevron_right
Development of Ru(II) Complexes: Next-Generation Anticancer Metallotherapeutics?
sreekanth thota
SYNERGY CONFERENCE-2017, CANCER PHARMACOLOGY RESEARCH, 2017
View PDFchevron_right
Inhibition of cancer cell growth by ruthenium complexes
Marc Purazo
Journal of translational medicine, 2016
View PDFchevron_right
In search for anticancer compounds; new bis(2-phenylazopyridine) ruthenium(II) complexes
Anna Hotze
Journal of Inorganic Biochemistry, 2003
View PDFchevron_right
Synthesis, characterization, antitumor, and cytotoxic activity of mononuclear Ru(II) complexes
Subhas Karki
Journal of Coordination Chemistry, 2010
View PDFchevron_right
Apoptotic Properties of Rutheinum Complexes on Different Type of Cancer Cell Lines
Hayati Türkmen
Proceedings
View PDFchevron_right
Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer Activity
Marco Antonio Mendoza
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Promising anticancer mono- and dinuclear ruthenium(iii) dithiocarbamato complexes: systematic solution studies
Chiara Nardon
Dalton Transactions, 2011
View PDFchevron_right
New platinum and ruthenium complexes--the latest class of potential chemotherapeutic drugs--a review of recent developments in the field
Michael Buratovich
Mini reviews in medicinal chemistry, 2009
View PDFchevron_right
Mono- and dinuclear (η6-arene) ruthenium(II) benzaldehyde thiosemicarbazone complexes: Synthesis, characterization and cytotoxicity
Denver Hendricks
Inorganic Chemistry Communications, 2011
View PDFchevron_right
Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru (II) complexes
sreekanth thota
Journal of Enzyme Inhibition and Medicinal Chemistry, 2010
View PDFchevron_right
Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
Romana Masnikosa
Coord Chem Rev, 2019
View PDFchevron_right
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
O. Novakova
Drug Resistance Updates, 2006
View PDFchevron_right
Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action
Ashoka Samuelson
Journal of Inorganic Biochemistry, 2010
View PDFchevron_right
Ruthenium anticancer compounds: Challenges and expectations
Ioannis Bratsos
Chimia, 2007
View PDFchevron_right
New half-sandwich ruthenium(II) complexes as proteosynthesis inhibitors in cancer cells
Enrique Ortega
View PDFchevron_right
Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes
Ana Tomaz
Journal of inorganic biochemistry, 2016
View PDFchevron_right
Design and synthesis of some ruthenium complexes as potential antitumour agents
Shyamal Kumar Chattopadhyay
Journal of Inorganic Biochemistry, 1991
View PDFchevron_right
The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549)
Cesar A S T Vilanova-Costa
View PDFchevron_right
SYNTHESIS, CHARACTERIZATION AND CYTOTOXIC ACTIVITY OF SOME Ru (II) COMPLEXES
sreekanth thota
Turkish Journal of Pharmaceutical Sciences, 2011
View PDFchevron_right
In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate-Based Ligands
Olivier Zava
Chemistry - A European Journal, 2008
View PDFchevron_right
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Wee Han Ang
European Journal of Inorganic Chemistry, 2006
View PDFchevron_right
Substitution-Modulated Anticancer Activity of Half-Sandwich Ruthenium(II) Complexes with Heterocyclic Ancillary Ligands
Ashoka Samuelson
2014
View PDFchevron_right
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Ana Isabel Tomaz
JBIC Journal of Biological Inorganic Chemistry, 2014
View PDFchevron_right